Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis

Published:2021-02 Issue: Volume:228 Page:218-226
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Campana Mattia,Falkai Peter,Siskind Dan,Hasan Alkomiet,Wagner Elias

Funder

Ludwig-Maximilians-Universität München

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference101 articles.

1. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial;Afshar;J. Psychopharmacol.,2008

2. Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial;Anghelescu;Eur. Neuropsychopharmacol.,1997

3. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety;Anil Yağcioğlu;Journal of clinical psychiatry,2005

4. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia;Arumugham;Expert Rev Clin Pharmacol Sep,2016

5. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial;Assion;Pharmacopsychiatry,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice;European Neuropsychopharmacology;2024-07

2. Nutraceuticals in Psychiatric Disorders: A Systematic Review;International Journal of Molecular Sciences;2024-04-28

3. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia;Schizophrenia Research;2023-12

4. Augmentation Strategies for Partial or Non-responders to Clozapine in Patients with Schizophrenia: A Bayesian Network Meta-analysis of Randomized Controlled Trials;Clinical Psychopharmacology and Neuroscience;2023-11-30

5. Opţiuni terapeutice în schizofrenia ultrarezistentă. Intervenţii nonfarmacologice (II);Psihiatru.ro;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3